黄金城游戏

Oxford Global is proud to present the 黄金城游戏 , taking place on 11 - 12 June 2019 in Berlin, Germany featuring over 20 presentations on the latest strategies & technologies impacting the neuroscience field.

Our 黄金城游戏 delivers an extensive look across the development process in the neuroscience field; from identifying & validating molecular targets to patient stratification & diagnostics. Further talks include an overview of biomarkers in neuroscience & the use of CRISPR screening.

Day one of the 黄金城游戏 will focus on the latest drug discovery strategies in CNS, including the use of iPS Cells in Neuropharmacology & the role of stem cell research in identifying neurodegenerative disorders. Delegates can further expect to benefit from the latest in neuroimaging. Day 2 will focus on biomarkers in patient stratification & identification of neurological disorders.

Key speakers include vice presidents, executive directors & heads from leading pharmaceutical & biotech companies such as Takeda, Boehringer Ingelheim & Novartis. The event is co-located with our well established 20th Annual Drug Discovery Summit, 7th Annual Discovery Chemistry & Drug Design Congress & the Bispecifics Drug Development Congress. This 2-day interactive 黄金城游戏 will allow delegates to discuss the latest industry & developments with over 500 senior level delegates.

2 Interactive Streams:

• Drug Discovery Strategies in CNS
• Translation, Stratification and Precision Medicine In Neuroscience
  

View the agenda: https://bit.ly/2RWq9TC

For further information about the 黄金城游戏, please contact Guillaume Alonso at [email protected] or visit the website https://bit.ly/2RW0RWp